CancerFax - Conquering cancer

💔 The Silence is Costing Lives: Why Women Delay Diagnosis 💔

Swipe through this critical carousel to understand the hidden barriers that prevent women from seeking early medical care, and how we can work together to change the narrative.

Here's what you'll see:

The Reality: It’s driven by Fear, Stigma, and Misinformation. Too many women wait when symptoms appear, putting their health at serious risk.

The Impact: Late diagnosis leads to advanced tumor growth, limited treatment options, and immense emotional hardship.

The Barriers: From the high cost of treatment to the fear of social judgment, we break down the obstacles.

How We Can Help: We need collective action to educate, encourage open conversations, and make screening accessible.

It's time to make early diagnosis the norm. Every conversation matters. Every voice counts.

ACTION STEPS:
Swipe and Share: Help us break the stigma by sharing this post.

Speak Up: Drop a comment below with your ideas on improving healthcare access!

#BreastCancerAwareness #HealthEquity #WomensHealth #EarlyDiagnosis #BreakingTheStigma #CommunityPost

Skip the Carousel

1 2 3 4 5 6

1 month ago (edited) | [YT] | 1

CancerFax - Conquering cancer

Exploring the safety and effectiveness of SKG0201 injections in individuals with Type 1 Spinal Muscular Atrophy.


Discover more about this clinical trial: buff.ly/sULxrlg


#SMA #ClinicalTrial

6 months ago | [YT] | 0

CancerFax - Conquering cancer

🧬 CAR T-Cell Therapy Now Available for Leukemia, Lymphoma, Multiple Myeloma, Liver Cancer, GI Cancer & Neuroblastoma 🧬

A new era of cancer treatment is here – and it’s transforming outcomes for even the most advanced-stage patients. CAR T-cell therapy (Chimeric Antigen Receptor T-cell therapy) is now offering groundbreaking results in diseases once considered incurable.

🔹 What is CAR T-Cell Therapy?
It’s a revolutionary treatment where a patient's own T-cells are genetically modified to recognize and attack cancer cells. These cells are then reintroduced into the patient to seek out and destroy tumors with precision and power.

🔬 Current Targets & Indications:

✅ Leukemia & Lymphoma
Targets:
• CD19 – Expressed on B-cell cancers like ALL and DLBCL
• CD20 – Found on mature B-cells in NHL
• CD22 – A key surface marker in relapsed B-cell malignancies
• CD5 & CD7 – Targets for T-cell lymphomas & leukemias

✅ Multiple Myeloma
• BCMA (B-cell maturation antigen) – Exclusively found on malignant plasma cells, making it a prime target for CAR T therapies.

✅ Neuroblastoma
• GD2 – Overexpressed on neuroblastoma cells, enabling highly targeted treatment for pediatric and adult cases.

✅ Gastric & GI Cancers
• Claudin 18.2 – A tight junction protein selectively overexpressed in gastric and pancreatic tumors.

✅ Liver Cancer (Hepatocellular Carcinoma)
• GPC3 (Glypican-3) – A tumor-specific marker seen in over 70% of HCC cases, not found in healthy adult tissues.

🌍 Why China? Leading the CAR T Revolution
With over 3,000+ CAR T and immunotherapy trials currently underway, China is the global leader in advanced-stage cancer clinical trials, far surpassing other countries. Their hospitals are now treating international patients using cutting-edge therapies years before they’re available elsewhere.

🌐 How CancerFax.com Helps
At CancerFax, we guide cancer patients from around the world to leading hospitals in China offering CAR T therapy. From medical report evaluation and clinical trial enrollment to travel and visa assistance, we handle everything so you can focus on healing.

💬 Thousands of patients have already taken their first step with us. It's your turn now.

📲 Visit www.cancerfax.com to explore treatment options, upload medical reports, or speak with our cancer experts directly.

✅ Breakthrough therapies are real. Access them now.

#CAR_TCellTherapy #CancerTreatment #Leukemia #Lymphoma #MultipleMyeloma #LiverCancer #Neuroblastoma #GastricCancer #Claudin18 #BCMA #GPC3 #CD19 #CD22 #GD2 #ChinaCancerCare #CancerFax #Immunotherapy #CellTherapy #FightCancer #CancerSurvivor #CancerAwareness #HopeLivesHere

7 months ago | [YT] | 0

CancerFax - Conquering cancer

A New Dawn in Cancer Treatment: CMU's Revolutionary Breakthrough

In a monumental stride towards conquering cancer, China Medical University (CMU) and the Healthcare System have unveiled groundbreaking advancements that promise to redefine the future of oncology.​

At the recent Healthcare+ Expo in Taiwan, CMU introduced the world's first allogeneic CAR-T therapy for solid tumors, developed by Ever Supreme Bio Technology. This innovative treatment has demonstrated an unprecedented tumor reduction rate of over 90% in pre-clinical studies, marking a significant leap in cancer therapy. ​

Furthering their commitment to precision medicine, CMU's collaboration with Kyoto University has led to the establishment of a global research center focusing on cancer research, regenerative medicine, and AI-powered drug discovery. ​

These advancements not only symbolize hope for millions battling cancer but also set new benchmarks in the biomedical industry.​

#InnovationInMedicine #CancerBreakthrough #CAR_TTherapy #CMUHealthcare #HopeForCancerPatients #MedicalRevolution #ViralPosts #CancerPosts

7 months ago | [YT] | 0

CancerFax - Conquering cancer

🌟 कैंसर इलाज में चीन की क्रांतिकारी खोज 🇨🇳 🌟

जब पूरी दुनिया कैंसर को मौत की सजा समझती है, चीन के वैज्ञानिकों ने इतिहास रच दिया है। 💥
उन्होंने ऐसा इलाज विकसित किया है जो ट्यूमर को सूअर के मांस की तरह दिखाता है, ताकि हमारा इम्यून सिस्टम उसे पहचानकर खत्म कर सके। 🧠💉

ये सिर्फ विज्ञान नहीं है, ये है उम्मीद की एक नई किरण, ज़िंदगी की एक और कोशिश, करोड़ों लोगों के लिए एक चमत्कार 🙏

CancerFax इस अद्भुत उपलब्धि को सलाम करता है। उन वैज्ञानिकों को धन्यवाद, जो नामुमकिन को मुमकिन बनाने में जुटे हैं।
हर कैंसर योद्धा के लिए — शायद यही वो रोशनी है जिसका इंतज़ार था। 💪🌈

🫀 चलिए साथ मिलकर कैंसर-मुक्त दुनिया की ओर एक और कदम बढ़ाते हैं।

#कैंसरइलाज #चमत्कार #चीनीविज्ञान #इम्यूनोथेरेपी #ViralPosts #CancerPosts #CancerHope #CancerWarrior #TumorTreatment #MedicalNews #कैंसरकीखबर #बीटिंगकैंसर #नईउम्मीद

7 months ago | [YT] | 1

CancerFax - Conquering cancer

🌟 BREAKTHROUGH IN CANCER TREATMENT FROM CHINA 🇨🇳 🌟

In a world that often sees cancer as a death sentence, Chinese scientists have just flipped the script. 💥
They've developed a pioneering treatment that tricks tumors into behaving like pork muscle — making them recognizable to the immune system, which then attacks and destroys them. 🧠💉

This is more than science.
This is hope reimagined, a miracle in the making, a lifeline for millions still fighting, still hoping. 🙏

At CancerFax, we stand in awe of such revolutionary progress. We salute the researchers who dare to dream beyond the known, and for every cancer warrior out there — this could be the light you've been waiting for. 💪🌈

🫀 Together, we move one step closer to a cancer-free world.

#CancerBreakthrough #CancerResearch #ChineseInnovation #Immunotherapy #ViralPosts #CancerPosts #CancerHope #CancerWarriors #TumorTreatment #ScienceMiracles #CancerCureSoon #HopeAgainstCancer #MedicalRevolution #CancerNews #CancerUpdate #BeatingCancer

7 months ago | [YT] | 1

CancerFax - Conquering cancer

Explore the latest advancements in bladder cancer treatment, offering hope and better outcomes. From innovative immunotherapy, which harnesses the body's immune system to combat cancer cells, to targeted therapy that focuses on specific molecular targets, these treatments are revolutionizing care.


Cutting-edge surgical techniques, such as robotic-assisted surgeries, enhance precision and recovery. With over 80,000 new cases annually in the U.S., these options provide significant promise.


#BladderCancer #InnovativeCare #CancerTreatment #MedicalAdvances #Immunotherapy #TargetedTherapy #SurgicalInnovation #HealthBreakthroughs


Learn more: cancerfax.com/immunotherapy-for-bladder-cancer/

8 months ago | [YT] | 1

CancerFax - Conquering cancer

Discovering the Power of Astraeus asiaticus: This remarkable mushroom holds promise as a potent anticancer and antioxidant resource. Known for its natural compounds, Astraeus asiaticus is gaining attention in the scientific community for its potential to combat cancer cells and reduce oxidative stress.



Studies indicate that it may inhibit tumor growth, offering hope for new cancer treatments. Additionally, its antioxidant properties help protect cells from damage caused by free radicals, contributing to overall health.

This groundbreaking study was conducted by Swapan Kumar Ghosh, Koushik Pandey, Madhuparna Ghosh, and Pradip Kumar Sur.

The research was carried out at the Molecular Mycopathology Lab, Cancer Research Unit, PG Department of Botany, Ramakrishna Mission Vivekananda Centenary College (Autonomous), Rahara, Kolkata, in collaboration with Midnapore City College, Shri Ramkrishna Institute of Medical Sciences and Sanaka Hospital, and Kanchrapara College in West Bengal, India.


Their collective expertise in botany, paramedical sciences, and zoology played a crucial role in unlocking the medicinal potential of Astraeus asiaticus.


Explore more about this natural powerhouse and its benefits: buff.ly/sKfmxbz



#CancerResearch #Antioxidants #HealthBenefits #MushroomPower #NaturalRemedies #TumorInhibition #OxidativeStress #ScientificDiscovery #HealthInnovation #AntiCancerMushroom

8 months ago | [YT] | 0

CancerFax - Conquering cancer

Inavolisib, when combined with palbociclib and fulvestrant, is emerging as a promising treatment for endocrine-resistant breast cancer. This innovative therapy specifically targets advanced cases that are PIK3CA-mutated and hormone receptor-positive but HER2-negative.


Research shows that approximately 40% of breast cancer patients have PIK3CA mutations, making this targeted approach crucial. By inhibiting the PI3K pathway, inavolisib can help overcome resistance to hormonal therapies, offering new hope for patients.


For more information, visit: buff.ly/N7bPiyZ


#BreastCancer #CancerResearch #PIK3CA #EndocrineResistance #AdvancedCancer #BreastCancerAwareness #InnovativeTherapy #HormoneTherapy #HER2Negative #ResearchBreakthrough

8 months ago | [YT] | 1

CancerFax - Conquering cancer

Exploring nivolumab as a pre- or post-surgical option for manageable non-small cell lung cancer. This promising study offers hope, aiming to improve survival rates and quality of life.


Nivolumab, an immunotherapy, boosts the body's defenses to fight cancer more effectively.


Learn about its role in revolutionizing lung cancer treatment here: buff.ly/TIUsOfq.


#LungCancer #Nivolumab #Immunotherapy #CancerResearch #HealthInnovation #LungHealth #MedicalAdvancements #PatientCare #Oncology #ClinicalTrials

8 months ago | [YT] | 0